SCHEMBL4394465

SCHEMBL4394465

O=C1CCC(Sc2ccccc2)O1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.45
PRSS1 P07477 2/20 0.45
CRBN Q96SW2 3/20 0.44
DDB1 Q16531 2/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CTRB1 P17538 1/20 0.38
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10992840 0.74 MEN1 (0.49) F2PRSS1CRBNDDB1MEN1
SCHEMBL9012682 0.71 TSHR (0.46) CTRB1CA1CA9ALDH1A1HPGD
SCHEMBL7339250 0.71 TSHR (0.46) CTRB1CA1CA9ALDH1A1HPGD
SCHEMBL982856 0.71 TSHR (0.46) CTRB1CA1CA9ALDH1A1HPGD
SCHEMBL6009333 0.70 F2 (0.41) F2PRSS1CRBNDDB1MEN1
SCHEMBL18124767 0.68 CYP2C19 (0.56) CRBNDDB1CTRB1CA1CA9
SCHEMBL11027739 0.68 F2 (0.36) F2PRSS1CRBNDDB1MEN1
SCHEMBL7493544 0.67
SCHEMBL4700938 0.67 CRBN (0.47) F2PRSS1CRBNDDB1MEN1
SCHEMBL7379470 0.66 MEN1 (0.48) MEN1KMT2ACTRB1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090305239-A1 Methods and compositions for determing a level of biologically active serum paraoxonase YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2009-12-10 US disclosed
EP-1915457-A2 METHODS AND COMPOSITIONS FOR DETERMINING A LEVEL OF BIOLOGICALLY ACTIVE SERUM PARAOXONASE YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2008-04-30 EP disclosed
WO-2007020632-A2 METHODS AND COMPOSITIONS FOR DETERMINING A LEVEL OF BIOLOGICALLY ACTIVE SERUM PARAOXONASE YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090305239-A1 Methods and compositions for determing a level of biologically active serum paraoxonase PON1, LPO, PNLIP F2 523/4885PRSS1 128/4885CRBN 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.